Chemist + Druggist is part of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Actavis UK rebrands as Accord Healthcare

Generics manufacturer Actavis UK has rebranded as Accord Healthcare this week, following its acquisition by India-based Intas Pharmaceuticals in January.

Actavis UK managing director Jonathan Wilson said pharmacists will “see some changes”. “Well, one big change to be precise – and that’s our name.”

“Rest assured that we’re just as committed to UK manufacturing and excellent service,” Mr Wilson said yesterday (April 3), the day the rebranding came into effect.

As part of the rebranding, the Actavis scheme for independent pharmacies is being relaunched as “the Accord scheme”, he said.

“The Accord scheme combines all of the benefits from the Actavis Accumulator and partner pricing schemes, along with some brand new features designed to support your current purchasing preferences,” Mr Wilson added.

Actavis UK was sold to Intas Pharmaceuticals – through its subsidiary Accord Healthcare – as part of a European Commission requirement before Teva was able to buy the Actavis Generics business.

Will the Actavis rebrand affect you?

Related Content

Topics



Pharmacy Dispenser/ Technician
Bethnal Green North, London
Salary: Up to £30,000

Apply Now
UsernamePublicRestriction

Register

CD008675

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel